Conditions: Allergic Rhinitis Chronic Urticaria
Keywords: Xyzal Levocetirizine Allergy Children Seasonal Allergies
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 69
Healthy volunteers: no

Brief summary:
To determine the safety of levocetirizine in children ages 6-11 months with symptoms of allergic rhinitis or chronic idiopathic urticaria.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Levocetirizine 1.25 mg intervention 2: Placebo
Intervention descriptions: intervention 1: Levocetirizine dihydrochloride 1.25 mg (5 drops containing 5 mg/mL) dosed once a day for 2 weeks intervention 2: Placebo oral liquid once a day for two weeks

Protocol document: